Abstract
Background: Historically, both systolic and diastolic blood pressures have been targeted to reduce cardiovascular (CV) mortality in the general population. Intensive systolic blood pressure (SBP) control reduces CV outcomes in non-diabetics (SPRINT trial), but not in diabetics (ACCORD trial). We
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
